The Parkinson’s Foundation announces centres for ‘under-served’ communities

News

Author: Joe McAweaneyPublished: 29 August 2019

Prep: Cook: Serves:

The Parkinson’s Foundation has announced the addition of three Centres of Excellence to its network of care facilities for people with Parkinson’s.

The centres, which are based in US states Colorado, Indiana and Pennsylvania, will primarily focus on ‘under-served’ (low income) communities which have less access to healthcare services – giving individuals from those areas priority in the application process.

The facilities will include specialised teams of neurologists, movement disorder specialists, mental health professionals and experts in Parkinson’s medication.

John L. Lehr, president of the Parkinson’s Foundation, said: “The newly designated Centers of Excellence join a network that is setting the highest standards of care for people with PD worldwide.

“We are proud to further our commitment to improving the quality of life for people with Parkinson’s and making a difference in under-served communities across the country.”

For more information on Parkinson’s and multidisciplinary care please visit the EPDA website.

To read more about this story click here.

Take part in a global Parkinson’s carers survey

Last Month

Next Month

Go Back

Share this story

Comments

Recipes & Nutrition

6 superfoods to enhance brain function in Parkinson’s

To improve brain function add more carrots and fish to your diet

Pearl barley risotto with southern vegetables

Rice is swapped for pearl barley in this risotto with a twist

Billy Connolly’s best Comic Relief moments

After his emotional appeal, we look at Billy's top fundraising moments

New wearable medical device for Parkinson’s disease to launch this year

The Imperial College London Innovation Fund, UK, has invested £205,000 to support UK-based tech company Charco Neurotech in its development of a non-invasive medical device for people with Parkinson’s disease. CUE1, a circular device that attaches to the sternum with medical adhesives, uses specialised vibration to help alleviate physical symptoms of Parkinson’s disease. Initial user testing among people with the condition found that the device improved movement by an average of 16%, with testers reporting benefits for walking and fine motor tasks. Lucy Jung, CEO and co-founder of Charco Neurotech, said: “We believe that CUE1 has the potential to significantly improve [Parkinson’s disease] symptoms through its unique controlled vibration technology. We are excited to continue our work on the device and we look forward to the outcome of our proposed clinical trials.” Charco Neurotech will use the Imperial College investment to initiate a clinical trial and fund the device’s manufacture for…

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”

Could a prostate drug lower the risk of Parkinson’s disease?

Researchers in the US, Denmark and China have found that a type of medication used to treat enlarged prostate, known as alpha-blockers, is associated with a lower risk of Parkinson’s disease. As part of the study, the research team analysed patient data from 150,000 men using medications like the alpha-blocker terazosin – which has previously been shown to slow Parkinson’s disease progression in animals – and compared their findings to data from 150,000 men using the alpha-blocker tamsulosin. They found that men taking terazosin were 12 to 37% less likely to develop Parkinson’s disease. Jacob Simmering, corresponding author of the study, said: “Despite the relative differences in population and health care system structure, we found a similar protective effect in both [the US and Denmark]. “If these results are confirmed through further investigation, especially a randomised clinical trial, terazosin may provide neuroprotection and potentially prevent – and not just manage…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

The Parkinson’s Foundation announces centres for ‘under-served’ communities

News

Author: Joe McAweaneyPublished: 29 August 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Recipes & Nutrition

6 superfoods to enhance brain function in Parkinson’s

Recipes & Nutrition

Pearl barley risotto with southern vegetables

Global update

Billy Connolly’s best Comic Relief moments

New wearable medical device for Parkinson’s disease to launch this year

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

Could a prostate drug lower the risk of Parkinson’s disease?

{title}

Subscribe

The Parkinson’s Foundation announces centres for ‘under-served’ communities

News

Author: Joe McAweaneyPublished: 29 August 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Recipes & Nutrition

6 superfoods to enhance brain function in Parkinson’s

Recipes & Nutrition

Pearl barley risotto with southern vegetables

Global update

Billy Connolly’s best Comic Relief moments

New wearable medical device for Parkinson’s disease to launch this year

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

Could a prostate drug lower the risk of Parkinson’s disease?

{title}

Subscribe

Sign in